Effects of rofecoxib on lipid oxidation in plasma and aortas of rats
-
Published:2015
Issue:4
Volume:2
Page:155-159
-
ISSN:2189-115X
-
Container-title:Fundamental Toxicological Sciences
-
language:en
-
Short-container-title:Fundam. Toxicol. Sci.
Author:
Miyajima Atsushi1, Amano Yasuha1, Kamamoto Takeyoshi1, Okamoto Masahiro1, Hirota Takashi1
Affiliation:
1. Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science
Publisher
Japanese Society of Toxicology
Reference19 articles.
1. Aldington, S., Shirtcliffe, P., Weatherall, M. and Beasley, R. (2005): Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy. N. Z. Med. J., 118, U1684. 2. Baron, J.A., Sandler, R.S., Bresalier, R.S., Lanas, A., Morton, D.G., Riddell, R., Iverson, E.R. and Demets, D.L. (2008): Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet, 372, 1756-1764. 3. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M.B., Hawkey, C.J., Hochberg, M.C., Kvien, T.K. and Schnitzer, T.J. (2000): Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N. Engl. J. Med., 343, 1520-1528. 4. Bresalier, R.S., Sandler, R.S., Quan, H., Bolognese, J.A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., Konstam, M.A. and Baron, J.A. (2005): Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med., 352, 1092-1102. 5. Gutteridge, J.M. (1995): Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem., 41, 1819-1828.
|
|